Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
of bioinformatics, artificial intelligence, and systems biology, with a focus on single-cell genomics and other omics layers to understand early deviations in cardiometabolic diseases. Candidates should have a strong
-
Clinical Professor of Orthopaedic Surgery with special focus on technology-driven fracture surgery and tissue healing (Fixed-Term, 5 Years) Department of Clinical Medicine Faculty of Health and
-
Human Centred Computing Section invites applicants for a 2-year Post Doctoral Fellowship in Computer Supported Cooperative Work (CSCW) in the NeuroGen Computing research project focusing on creating
-
will join a vibrant group of interdisciplinary scientists in eg bioinformatics, cell biology, physiology and genomics. Project focus The postdoctoral researcher will lead experimental and/or
-
physiology models of organs. You will join a vibrant group of interdisciplinary scientists in eg bioinformatics, cell biology, gene editing and material science. Qualifications Applicants should hold (or be
-
Applicants should hold (or be close to completing) a PhD in biology, bioinformatics, genomics, or molecular physiology. We particularly welcome candidates with: Expertise in experimental genomics, cell biology
-
consequences of protein modification, a process known to be of major importance in cardiovascular disease as well as other human diseases associated with inflammation. We use a range of analytical, biochemical
-
, pharmacologists and structural biologists. Profile We are looking for a database developer with a computer science or similar background. Essential experience and skills: A MSc related to bioinformatics
-
science and be exposed to the biotech start-up community in the greater Copenhagen area. In parallel as part of PLEN, the Post Doc fellow will be interacting leading scientist within the fields of plant
-
GPCRs and related proteins, which are involved numerous physiological and pathophysiological processes and account for over 30% of targets for currently approved drugs. The Autzen group utilizes a range